1. Home
  2. PDT vs TMCI Comparison

PDT vs TMCI Comparison

Compare PDT & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDT
  • TMCI
  • Stock Information
  • Founded
  • PDT 1989
  • TMCI 2014
  • Country
  • PDT United States
  • TMCI United States
  • Employees
  • PDT N/A
  • TMCI N/A
  • Industry
  • PDT Finance Companies
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PDT Finance
  • TMCI Health Care
  • Exchange
  • PDT Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • PDT 636.9M
  • TMCI 516.6M
  • IPO Year
  • PDT N/A
  • TMCI 2021
  • Fundamental
  • Price
  • PDT $13.03
  • TMCI $8.15
  • Analyst Decision
  • PDT
  • TMCI Hold
  • Analyst Count
  • PDT 0
  • TMCI 8
  • Target Price
  • PDT N/A
  • TMCI $9.00
  • AVG Volume (30 Days)
  • PDT 145.6K
  • TMCI 346.3K
  • Earning Date
  • PDT 01-01-0001
  • TMCI 05-06-2025
  • Dividend Yield
  • PDT 8.88%
  • TMCI N/A
  • EPS Growth
  • PDT N/A
  • TMCI N/A
  • EPS
  • PDT N/A
  • TMCI N/A
  • Revenue
  • PDT N/A
  • TMCI $209,357,000.00
  • Revenue This Year
  • PDT N/A
  • TMCI $10.86
  • Revenue Next Year
  • PDT N/A
  • TMCI $10.06
  • P/E Ratio
  • PDT N/A
  • TMCI N/A
  • Revenue Growth
  • PDT N/A
  • TMCI 11.88
  • 52 Week Low
  • PDT $8.77
  • TMCI $3.92
  • 52 Week High
  • PDT $13.05
  • TMCI $12.74
  • Technical
  • Relative Strength Index (RSI)
  • PDT 57.88
  • TMCI 40.85
  • Support Level
  • PDT $12.81
  • TMCI $8.34
  • Resistance Level
  • PDT $13.12
  • TMCI $8.87
  • Average True Range (ATR)
  • PDT 0.16
  • TMCI 0.41
  • MACD
  • PDT 0.03
  • TMCI 0.03
  • Stochastic Oscillator
  • PDT 85.94
  • TMCI 35.71

About PDT John Hancock Premium Dividend Fund

John Hancock Premium Div Fund is a United States-based closed-end management investment company. It seeks to provide a high current income consistent with modest growth of capital. The fund will pursue its objective by investing in a diversified portfolio comprised of dividend-paying preferred securities and common equity securities. The portfolio composition of the fund consists of preferred securities, common stocks, corporate bonds, capital preferred securities, and short-term investments.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: